HMGB1 and neoplasm: In synergy with immunotherapy, dying tumor cells undergoing ferroptosis or cuproptosis release a series of damage-associated molecular patterns (DAMPs), including ATP, calreticulin (CRT), and high-mobility group box 1 (HMGB1) [194, 195].